170 results on '"Dixon, Lana"'
Search Results
2. Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2
3. What do patients want from a digital device that supports heart failure self-management?
4. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
5. The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction
6. SGLT2 Inhibition in Heart Failure: Clues to Cardiac Effects?
7. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
8. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
9. 155 Impact of SGLT2 inhibition on reverse cardiac remodeling in patients with heart failure: a systematic review and meta-analysis
10. An insight into healthcare professionals’ perspectives on discussing implantable cardioverter defibrillator deactivation
11. Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction
12. An insight into healthcare professionals' perspectives on discussing implantable cardioverter defibrillator deactivation
13. Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care
14. 147 Symptomatic benefit from sglt2 inhibition is independent of degree of lv reverse remodelling – a real world study
15. Using ERIC on CD/ROM (A Guide to the Basics).
16. Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.
17. Challenges in heart failure care in four European countries: a comparative study
18. Inadequate Communication Exacerbates the Support Needs of Current and Bereaved Caregivers in Advanced Heart Failure and Impedes Shared Decision-making
19. Inadequate Communication Exacerbates the Support Needs of Current and Bereaved Caregivers in Advanced Heart Failure and Impedes Shared Decision-making
20. An exploration of the prevalence and experience of cardiac cachexia: protocol for a mixed methods cross-sectional study
21. Factors in Science Journal Cancellation Projects: The Roles of Faculty Consultations and Data
22. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
23. Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial Survey
24. Poster Abstract: Cardiac Cachexia: Diagnostic Complications with Focusing on Weight Loss
25. Exploring the prevalence, impact and experience of cardiac cachexia in patients with advanced heart failure and their caregivers: A sequential phased study:A sequential phased study
26. Exploring the prevalence, impact and experience of cardiac cachexia in patients with advanced heart failure and their caregivers: A sequential phased study
27. 122 Real world outcomes of sglt2 inhibition in a hfref population
28. The impact & experience of cardiac cachexia in patients with advanced heart failure & their caregivers
29. The impact & experience of cardiac cachexia in patients with advanced heart failure & caregivers
30. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction.
31. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction
32. sj-pdf-1-pmj-10.1177_02692163221101748 – Supplemental material for Exploring the prevalence, impact and experience of cardiac cachexia in patients with advanced heart failure and their caregivers: A sequential phased study
33. Building Library Skills: Computer-Assisted Instruction for Undergraduates.
34. Patientsʼ perception of implantable cardioverter defibrillator deactivation at the end of life
35. Determinants of acceptance of patients with heart failure and their informal caregivers regarding an interactive decision-making system: a qualitative study
36. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making.
37. The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction
38. An unusual case of mid-ventricular Takotsubo cardiomyopathy
39. Tako-Tsubo Cardiomyopathy Presenting With Acute Pulmonary Edema
40. NAD(P)H-dependent superoxide production in platelets: The role of angiotensin II and protein kinase C
41. The great masquerader strikes again cardiac sarcoid- an unusual cause of sudden cardiac arrest [7586] ESC HFA Congress
42. Early Detection of Anthracycline Induced Cardiomyopathy in Survivors of Childhood Cancer
43. One stop heart failure clinic a real world experience [7584] ESC HFA Congress
44. Early paradoxical steroid induced ventricular tachycardia in cardiac sarcoidosis [7585] ESC HFA Congress
45. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making
46. 96 The prognostic role of mid-range ejection fraction following ST elevation myocardial infarction
47. Production of 8-epi prostaglandin F2α in human platelets during administration of organic nitrates
48. ‘The importance of planning for the future’: Burden and unmet needs of caregivers’ in advanced heart failure: A mixed methods study
49. 'The importance of planning for the future': Burden and unmet needs of caregivers' in advanced heart failure: A mixed methods study.
50. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.